サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1477166

バイオ医薬品およびバイオメディシン市場：製品タイプ別、用途別、治療分野別、国別、地域別- 産業分析、市場規模、市場シェア、2024年～2032年の予測

Biopharmaceutical and Biomedicine Market, By Product Type, By Application, By Therapeutic Area, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 300 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.08円
バイオ医薬品およびバイオメディシン市場：製品タイプ別、用途別、治療分野別、国別、地域別- 産業分析、市場規模、市場シェア、2024年～2032年の予測
出版日: 2024年05月01日
発行: AnalystView Market Insights
ページ情報: 英文 300 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

バイオ医薬品およびバイオメディシンの市場規模は2023年に6,213億1,200万米ドルとなり、2024年から2032年にかけてCAGR 9.5％で拡大

生物医薬品と生物医学市場-市場力学

バイオ医薬品およびバイオメディシンセクターにおける製品上市と承認の急増

バイオ医薬品およびバイオメディシンセクターでは、製品の上市・承認率が顕著に急上昇しており、業界の急速な革新と拡大を示しています。米国食品医薬品局（FDA）のデータによると、近年、規制当局の承認を受けたバイオ医薬品の数は着実に増加しており、新薬の承認数は毎年過去最高を記録しています。この動向は、画期的なバイオ医薬品・バイオメディシン製品の開発を通じて、満たされていない医療ニーズに対応し、患者の転帰を改善するという業界のコミットメントを強調しています。

バイオ医薬品およびバイオメディシン市場-主要インサイト

弊社のリサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約9.5%のCAGRで毎年成長すると予測されています。

製品タイプ別では、モノクローナル抗体が2023年に最大の市場シェアを示すと予測されています。

用途別では、2023年には治療薬が主要タイプとなっています。

地域別では、北米が2023年の売上高をリードしています。

バイオ医薬品およびバイオメディシン市場-セグメンテーション分析：

バイオ医薬品およびバイオメディシンの世界市場は、製品タイプ、用途、治療分野、地域に基づいてセグメント化されます。

市場は製品タイプによって2つのカテゴリーに分けられる：モノクローナル抗体は、がん治療や自己免疫疾患などの治療用途に広く使用されています。ナノメディシンは、分子レベルで病気の診断、治療、予防を行うもので、ドラッグデリバリーやイメージングアプリケーションにおいて、標的を絞ったデリバリーや有効性の向上を提供します。

市場は用途によって3つのカテゴリーに分けられる：疾病や病状の治療に利用されます。診断薬は、病気や状態を特定し診断するために使用されます。研究開発は、創薬や薬剤開発のための科学研究や実験的研究に応用されます。

バイオ医薬品と生物医学市場-地理的洞察

地理的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東アフリカの地域に広がっています。これらの地域は、ビジネスをもたらす国によってさらに分けられます。

北米と欧州は、先進的なヘルスケア・インフラ、強固な研究開発能力、有利な規制環境を誇り、主要なプレーヤーとして位置づけられています。一方、アジア太平洋地域は、医療費の増加、慢性疾患の蔓延、革新的な治療法へのアクセス拡大を背景に、大きな成長の可能性を示しています。ラテンアメリカと中東・アフリカ地域も、医療インフラ、医療費負担の軽減、規制の複雑さといった課題はあるもの、市場拡大の可能性を秘めています。

バイオ医薬品およびバイオメディシン市場-競合情勢：

複数の主要企業が、研究開発投資、M&A、戦略的提携などの戦略を通じて覇権を争っています。ロシュ、ファイザー、ジョンソン・エンド・ジョンソンなどの企業は、バイオ医薬品の多様なポートフォリオと広範な世界展開で市場をリードしています。さらに、アムジェン、バイオジェン、ギリアド・サイエンシズといった革新的なバイオテクノロジー企業も、画期的な治療法や新薬候補で市場競争に貢献しています。競合が激化する中、各社は製品の革新、規制当局の承認、市場拡大の努力を通じて差別化に注力しています。

目次

第1章 バイオ医薬品およびバイオメディシン市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 バイオ医薬品およびバイオメディシンの主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 バイオ医薬品およびバイオメディシン産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 バイオ医薬品およびバイオメディシン市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 バイオ医薬品およびバイオメディシン市場情勢

  • バイオ医薬品およびバイオメディシン市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 バイオ医薬品およびバイオメディシン市場：製品タイプ別

  • 概要
    • 製品タイプ別セグメントシェア分析
    • モノクローナル抗体
      • ワクチン
      • 組み換えヒトインスリン
      • ヒト成長ホルモン
      • エリスロポエチン
      • インターフェロン
      • その他
    • ナノ医療
      • 細胞・遺伝子治療
      • バイオインフォマティクス
      • 分子酵素とキット

第8章 バイオ医薬品およびバイオメディシン市場：用途別

  • 概要
    • 用途別セグメントシェア分析
    • 治療薬
    • 診断
    • 研究開発

第9章 バイオ医薬品およびバイオメディシン市場：治療分野別

  • 概要
    • 治療分野別セグメントシェア分析
    • 腫瘍学
    • 神経学
    • 心臓病学
    • 免疫学
    • 感染症
    • 希少疾患

第10章 バイオ医薬品およびバイオメディシン市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析：バイオ医薬品およびバイオメディシン業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Amgen Inc.
    • F. Hoffmann-La Roche Ltd
    • Johnson &Johnson Services, Inc.
    • Pfizer Inc.
    • Sanofi
    • Eli Lilly and Company
    • AbbVie Inc.
    • Novo Nordisk A/S
    • Bristol-Myers Squibb Company
    • NanoString
    • QIAGEN
    • Affimed GmbH
    • GSK plc.
    • Merck KgaA
    • Teva Pharmaceutical Industries Ltd.
    • Others

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Biopharmaceutical and Biomedicine Market: Product Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Biopharmaceutical and Biomedicine Market, by Product Type 2019-2032 (USD Million)
  • TABLE Biopharmaceutical and Biomedicine Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Biopharmaceutical and Biomedicine Market, by Application 2019-2032 (USD Million)
  • TABLE Biopharmaceutical and Biomedicine Market: Therapeutic Area Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Therapeutic Area
  • TABLE Global Biopharmaceutical and Biomedicine Market, by Therapeutic Area 2019-2032 (USD Million)
  • TABLE Biopharmaceutical and Biomedicine Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Biopharmaceutical and Biomedicine Market, by Region 2019-2032 (USD Million)
  • TABLE North America Biopharmaceutical and Biomedicine Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Biopharmaceutical and Biomedicine Market, by Product Type, 2019-2032 (USD Million)
  • TABLE North America Biopharmaceutical and Biomedicine Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Biopharmaceutical and Biomedicine Market, by Therapeutic Area, 2019-2032 (USD Million)
  • TABLE Europe Biopharmaceutical and Biomedicine Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Biopharmaceutical and Biomedicine Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Europe Biopharmaceutical and Biomedicine Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Biopharmaceutical and Biomedicine Market, by Therapeutic Area, 2019-2032 (USD Million)
  • TABLE Asia Pacific Biopharmaceutical and Biomedicine Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Biopharmaceutical and Biomedicine Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Biopharmaceutical and Biomedicine Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Biopharmaceutical and Biomedicine Market, by Therapeutic Area, 2019-2032 (USD Million)
  • TABLE Latin America Biopharmaceutical and Biomedicine Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Biopharmaceutical and Biomedicine Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Latin America Biopharmaceutical and Biomedicine Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Biopharmaceutical and Biomedicine Market, by Therapeutic Area, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Biopharmaceutical and Biomedicine Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Biopharmaceutical and Biomedicine Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Biopharmaceutical and Biomedicine Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Biopharmaceutical and Biomedicine Market, by Therapeutic Area, 2019-2032 (USD Million)
目次
Product Code: ANV2564

REPORT HIGHLIGHT

Biopharmaceutical and Biomedicine Market size was valued at USD 621,312 Million in 2023, expanding at a CAGR of 9.5% from 2024 to 2032.

The biopharmaceutical and biomedicine market encompasses the development, production, and commercialization of pharmaceuticals and medical products derived from biological sources. The growing adoption of precision medicine and personalized therapies, advancements in biotechnology such as gene editing and cell therapy, and increased focus on rare diseases and orphan drugs. However, restraints in the biopharmaceutical and biomedicine market include stringent regulatory requirements, high research and development costs, and challenges related to manufacturing and scaling up production. Opportunities abound in emerging markets, expansion into therapeutic areas with unmet medical needs, and strategic collaborations and partnerships for drug discovery and development.

Biopharmaceutical and Biomedicine Market- Market Dynamics

Surging rates of product launches and approvals in the biopharmaceuticals and biomedicines sector

The biopharmaceuticals and biomedicines sector is witnessing a notable surge in rates of product launches and approvals, indicative of the industry's rapid innovation and expansion. According to data from the U.S. Food and Drug Administration (FDA), there has been a steady increase in the number of biopharmaceutical products receiving regulatory approval in recent years, with a record number of new drug approvals reported annually. This trend underscores the industry's commitment to addressing unmet medical needs and improving patient outcomes through the development of groundbreaking biopharmaceutical and biomedicine products.

Biopharmaceutical and Biomedicine Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.5% over the forecast period (2024-2032)

Based on product type segmentation, Monoclonal Antibodies were predicted to show maximum market share in the year 2023

Based on application segmentation, Therapeutics was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Biopharmaceutical and Biomedicine Market- Segmentation Analysis:

The Global Biopharmaceutical and Biomedicine Market is segmented based on Product Type, Application, Therapeutic Area, and Region.

The market is divided into two categories based on product type: Monoclonal Antibodies widely used in therapeutic applications such as cancer treatment and autoimmune diseases. Nanomedicine is for diagnosing, treating, and preventing diseases at the molecular level, offering targeted delivery and enhanced efficacy in drug delivery and imaging applications.

The market is divided into three categories based on application: Utilized for treating diseases and medical conditions. Diagnostics are used for identifying and diagnosing diseases or conditions. Research and Development are applied in scientific research and experimental studies for drug discovery and development.

Biopharmaceutical and Biomedicine Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

North America and Europe stand as key players, boasting advanced healthcare infrastructure, robust research and development capabilities, and favorable regulatory environments. Meanwhile, the Asia-Pacific region demonstrates significant growth potential, driven by rising healthcare expenditures, increasing prevalence of chronic diseases, and expanding access to innovative therapies. Latin America and the Middle East & Africa regions also present opportunities for market expansion, albeit with challenges related to healthcare infrastructure, affordability, and regulatory complexities.

Biopharmaceutical and Biomedicine Market- Competitive Landscape:

Several key players vie for dominance through strategies such as research and development investments, mergers and acquisitions, and strategic partnerships. Companies including Roche, Pfizer, and Johnson & Johnson lead the market with diverse portfolios of biopharmaceutical products and extensive global reach. Additionally, innovative biotechnology firms such as Amgen, Biogen, and Gilead Sciences contribute to market competitiveness with groundbreaking therapies and novel drug candidates. As competition intensifies, companies focus on differentiation through product innovation, regulatory approvals, and market expansion efforts.

Recent Developments:

In May 2022, JSR Life Sciences unveiled a new business division called Similis Bio, aimed at collaborating with biopharmaceutical firms to enhance efficiency and lower costs associated with biosimilar development.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIOPHARMACEUTICAL AND BIOMEDICINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Amgen Inc.

F. Hoffmann-La Roche Ltd

Johnson & Johnson Services, Inc.

Pfizer Inc.

Sanofi

Eli Lilly and Company

AbbVie Inc.

Novo Nordisk A/S

Bristol-Myers Squibb Company

NanoString

QIAGEN

Affimed GmbH

GSK plc.

Merck KgaA

Teva Pharmaceutical Industries Ltd.

Others

GLOBAL BIOPHARMACEUTICAL AND BIOMEDICINE MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Monoclonal Antibodies
  • Vaccines
  • Recombinant Human Insulin
  • Human Growth Hormone
  • Erythropoietin
  • Interferon
  • Others
  • Nanomedicine
  • Cell & Gene Therapy
  • Bioinformatics
  • Molecular Enzymes & Kits

GLOBAL BIOPHARMACEUTICAL AND BIOMEDICINE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Therapeutics
  • Diagnostics
  • Research and Development

GLOBAL BIOPHARMACEUTICAL AND BIOMEDICINE MARKET, BY THERAPEUTIC AREA- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Neurology
  • Cardiology
  • Immunology
  • Infectious Diseases
  • Rare Diseases

GLOBAL BIOPHARMACEUTICAL AND BIOMEDICINE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Biopharmaceutical and Biomedicine Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Biopharmaceutical and Biomedicine Market Snippet by Product Type
    • 2.1.2.Biopharmaceutical and Biomedicine Market Snippet by Application
    • 2.1.3.Biopharmaceutical and Biomedicine Market Snippet by Therapeutic Area
    • 2.1.4.Biopharmaceutical and Biomedicine Market Snippet by Country
    • 2.1.5.Biopharmaceutical and Biomedicine Market Snippet by Region
  • 2.2.Competitive Insights

3.Biopharmaceutical and Biomedicine Key Market Trends

  • 3.1.Biopharmaceutical and Biomedicine Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Biopharmaceutical and Biomedicine Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Biopharmaceutical and Biomedicine Market Opportunities
  • 3.4.Biopharmaceutical and Biomedicine Market Future Trends

4.Biopharmaceutical and Biomedicine Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Biopharmaceutical and Biomedicine Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Biopharmaceutical and Biomedicine Market Landscape

  • 6.1.Biopharmaceutical and Biomedicine Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Biopharmaceutical and Biomedicine Market - By Product Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2.Monoclonal Antibodies
      • 7.1.2.1.Vaccines
      • 7.1.2.2.Recombinant Human Insulin
      • 7.1.2.3.Human Growth Hormone
      • 7.1.2.4.Erythropoietin
      • 7.1.2.5.Interferon
      • 7.1.2.6.Others
    • 7.1.3.Nanomedicine
      • 7.1.3.1.Cell & Gene Therapy
      • 7.1.3.2.Bioinformatics
      • 7.1.3.3.Molecular Enzymes & Kits

8.Biopharmaceutical and Biomedicine Market - By Application

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2.Therapeutics
    • 8.1.3.Diagnostics
    • 8.1.4.Research and Development

9.Biopharmaceutical and Biomedicine Market - By Therapeutic Area

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By Therapeutic Area, 2023 & 2032 (%)
    • 9.1.2.Oncology
    • 9.1.3.Neurology
    • 9.1.4.Cardiology
    • 9.1.5.Immunology
    • 9.1.6.Infectious Diseases
    • 9.1.7.Rare Diseases

10.Biopharmaceutical and Biomedicine Market- By Geography

  • 10.1.Introduction
    • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2.North America
    • 10.2.1.Overview
    • 10.2.2.Biopharmaceutical and Biomedicine Key Manufacturers in North America
    • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4.North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6.North America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.2.7.U.S.
      • 10.2.7.1.Overview
      • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3.U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5.U.S. Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.2.8.Canada
      • 10.2.8.1.Overview
      • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3.Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5.Canada Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 10.3.Europe
    • 10.3.1.Overview
    • 10.3.2.Biopharmaceutical and Biomedicine Key Manufacturers in Europe
    • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4.Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6.Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.3.7.Germany
      • 10.3.7.1.Overview
      • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3.Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5.Germany Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.3.8.Italy
      • 10.3.8.1.Overview
      • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3.Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5.Italy Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.3.9.United Kingdom
      • 10.3.9.1.Overview
      • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3.United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5.United Kingdom Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.3.10.France
      • 10.3.10.1.Overview
      • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3.France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5.France Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.3.11.Russia
      • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2.Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4.Russia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.3.12.Netherlands
      • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2.Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4.Netherlands Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.3.13.Sweden
      • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2.Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4.Sweden Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.3.14.Poland
      • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2.Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4.Poland Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.3.15.Rest of Europe
      • 10.3.15.1.Overview
      • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5.Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 10.4.Asia Pacific (APAC)
    • 10.4.1.Overview
    • 10.4.2.Biopharmaceutical and Biomedicine Key Manufacturers in Asia Pacific
    • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4.Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6.Asia Pacific Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.4.7.India
      • 10.4.7.1.Overview
      • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3.India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5.India Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.4.8.China
      • 10.4.8.1.Overview
      • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3.China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5.China Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.4.9.Japan
      • 10.4.9.1.Overview
      • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3.Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5.Japan Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.4.10.South Korea
      • 10.4.10.1.Overview
      • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3.South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5.South Korea Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.4.11.Australia
      • 10.4.11.1.Overview
      • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3.Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5.Australia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.4.12.Thailand
      • 10.4.12.1.Overview
      • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3.Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5.Thailand Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.4.13.Indonesia
      • 10.4.13.1.Overview
      • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3.Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5.Indonesia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.4.14.Philippines
      • 10.4.14.1.Overview
      • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3.Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5.Philippines Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.4.15.Rest of APAC
      • 10.4.15.1.Overview
      • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3.Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5.Rest of APAC Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 10.5.Latin America
    • 10.5.1.Overview
    • 10.5.2.Biopharmaceutical and Biomedicine Key Manufacturers in Latin America
    • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4.Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6.Latin America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.5.7.Brazil
      • 10.5.7.1.Overview
      • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3.Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5.Brazil Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.5.8.Mexico
      • 10.5.8.1.Overview
      • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3.Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5.Mexico Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.5.9.Argentina
      • 10.5.9.1.Overview
      • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3.Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5.Argentina Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.5.10.Colombia
      • 10.5.10.1.Overview
      • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3.Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5.Colombia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.5.11.Rest of LATAM
      • 10.5.11.1.Overview
      • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5.Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 10.6.Middle East and Africa
    • 10.6.1.Overview
    • 10.6.2.Biopharmaceutical and Biomedicine Key Manufacturers in Middle East and Africa
    • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4.Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6.Middle East and Africa Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.6.7.Saudi Arabia
      • 10.6.7.1.Overview
      • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5.Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.6.8.United Arab Emirates
      • 10.6.8.1.Overview
      • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5.United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.6.9.Israel
      • 10.6.9.1.Overview
      • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3.Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5.Israel Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.6.10.Turkey
      • 10.6.10.1.Overview
      • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3.Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5.Turkey Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.6.11.Algeria
      • 10.6.11.1.Overview
      • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3.Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5.Algeria Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.6.12.Egypt
      • 10.6.12.1.Overview
      • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3.Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5.Egypt Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.6.13.Rest of MEA
      • 10.6.13.1.Overview
      • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3.Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5.Rest of MEA Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Biopharmaceutical and Biomedicine Industry

  • 11.1.Competitive Dashboard
  • 11.2.Company Profiles
    • 11.2.1.Amgen Inc.
    • 11.2.2.F. Hoffmann-La Roche Ltd
    • 11.2.3.Johnson & Johnson Services, Inc.
    • 11.2.4.Pfizer Inc.
    • 11.2.5.Sanofi
    • 11.2.6.Eli Lilly and Company
    • 11.2.7.AbbVie Inc.
    • 11.2.8.Novo Nordisk A/S
    • 11.2.9.Bristol-Myers Squibb Company
    • 11.2.10.NanoString
    • 11.2.11.QIAGEN
    • 11.2.12.Affimed GmbH
    • 11.2.13.GSK plc.
    • 11.2.14.Merck KgaA
    • 11.2.15.Teva Pharmaceutical Industries Ltd.
    • 11.2.16.Others

12.360 Degree Analyst View

13.Appendix

  • 13.1.Research Methodology
  • 13.2.References
  • 13.3.Abbreviations
  • 13.4.Disclaimer
  • 13.5.Contact Us